Elias Kouchakji
2020
Compensation breakdown
Non-Equity Incentive Plan | $259,065 |
---|---|
Option Awards | $1,001,625 |
Salary | $570,000 |
Stock Awards | $990,375 |
Other | $64,215 |
Total | $2,885,280 |
Kouchakji received $1M in option awards, accounting for 35% of the total pay in 2020.
Kouchakji also received $259.1K in non-equity incentive plan, $570K in salary, $990.4K in stock awards and $64.2K in other compensation.
Rankings
In 2020, Elias Kouchakji's compensation ranked 4,011th out of 13,090 executives tracked by ExecPay. In other words, Kouchakji earned more than 69.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,011 | 69th |
Manufacturing | 1,616 | 71st |
Chemicals And Allied Products | 616 | 73rd |
Drugs | 532 | 73rd |
Pharmaceutical Preparations | 406 | 72nd |
Pay ratio
Elias Kouchakji's Pay | $2,885,280 |
---|---|
Median Employee's Pay | $177,952 |
Pay Ratio | 16to 1 |
In 2020, the annual total compensation of Elias Kouchakji was $2,885,280.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of Elias Kouchakji's pay to the pay of median employee was therefore 16 to one.
Kouchakji's colleagues
We found seven more compensation records of executives who worked with Elias Kouchakji at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Thane Wettig
FibroGen
Chief Commercial Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
K Yu
FibroGen
Chief Medical Officer
2020
Pat Cotroneo
FibroGen
Chief Financial Officer
2020
Christine Chung
FibroGen
Senior Vice President, China Operations
2020
James Schoeneck
FibroGen